ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
바소프레서 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 성장률(CAGR) 6.9%로 49억 2,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 고혈압 유병률 증가, 고급 패혈증 관리 가이드라인 채택 확대, 중환자 치료 기술에 대한 투자 증가, 패혈증성 쇼크 유병률 증가, 개별화된 중환자 치료에 대한 수요 증가 등 여러 가지 요인에 기인합니다. 이 기간의 주요 동향으로는 약물 제제의 발전, 맞춤형 치료법 개발, 스마트 수액 펌프의 혁신, 원격의료와 바소프레서 치료의 통합, 생분해성 바소프레서 임플란트 기술 혁신 등이 있습니다.
심장 질환의 유병률 증가는 향후 몇 년 동안 바소프레서 시장의 성장을 촉진할 것으로 예상됩니다. 심장질환에는 관상동맥질환, 부정맥, 심부전, 선천성 심장질환 등 심장의 구조와 기능에 영향을 미치는 다양한 질환이 포함됩니다. 좌식 생활이 증가함에 따라 비만과 심혈관계 건강 상태의 악화가 보편화되면서 심장 관련 질환의 위험이 크게 증가하고 있습니다. 혈관수축제는 혈관을 수축시켜 혈압을 상승시키고, 중요한 장기로의 혈류를 촉진하며, 중요한 조건에서 심혈관계 기능을 지원함으로써 심장 질환의 치료를 돕습니다. 예를 들어, 2023년 12월 호주 정부 기관인 호주 보건 복지 연구소는 관상동맥성 심장 질환(CHD)으로 인한 의사 진단 사망자 수가 2021년 1만 4,100명에서 2022년 1만 4,900명으로 증가했다고 보고했습니다. 결과적으로 심장질환의 증가율이 심폐소생술 시장 성장에 기여하고 있습니다.
바소프레서 시장의 신흥국 기업들은 혈압을 더 잘 조절하고 환자의 예후를 개선하기 위해 정맥 내(IV) 혈관압박제와 같은 첨단 솔루션 개발에 주력하고 있습니다. 정맥 내 혈관압박기는 중증 저혈압이나 쇼크 상태에 있는 환자의 혈관을 수축시키고 혈압을 상승시켜 중요한 장기에 충분한 혈류를 보장하는 데 사용됩니다. 예를 들어, 독일에 본사를 둔 제약사 프레제니우스 카비 AG는 2023년 6월 바소프레신 주사액 USP를 미국 시장에 출시해 중환자 치료 제품 라인업을 확대했습니다. 이 약은 수액이나 카테콜아민 투여 후에도 저혈압이 지속되는 혈관확장성 쇼크 성인에게 특히 적응증을 가지고 있습니다. 이 약은 1mL당 20유닛을 함유한 1회용 바이알입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 바소프레서 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 바소프레서 시장 : 성장률 분석
세계의 바소프레서 시장 실적 : 규모와 성장, 2019-2024
세계의 바소프레서 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 바소프레서 전체 시장(TAM)
제6장 시장 세분화
세계의 바소프레서 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
카테콜아민
비카테콜아민
바소프레신
세계의 바소프레서 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
정맥내(IV)
골내
흡입
세계의 바소프레서 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
저혈압 관리
패혈증성 쇼크 치료
심장성 쇼크 서포트
수술 후 관리
기타 집중 치료 애플리케이션
세계의 바소프레서 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
외래 수술 센터
응급의료 서비스
재택 케어 설정
세계의 바소프레서 시장 카테콜아민 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
노르에피네프린
에피네프린
도파민
이소프로테레노르
세계의 바소프레서 시장, 비카테콜아민 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
페닐에프린
안지오텐신 II
세계의 바소프레서 시장 바소프레신 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
바소프레신(데스모프레신)
제7장 지역별·국가별 분석
세계의 바소프레서 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 바소프레서 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
바소프레서 시장 : 경쟁 구도
바소프레서 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck And Co Inc. Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Bauch & Lomb Incorporated
Dr. Reddy's Laboratories Limited
Hikma Pharmaceuticals PLC
Endo Inc.
Amphastar Pharmaceuticals Inc.
American Regent Incorporated
Celon Laboratories Ltd.
Athenex Inc.
Sagent Pharmaceuticals Inc.
Civica Rx
Eton Pharmaceuticals Inc.
Amomed Pharma GmbH
Health Biotech Limited
Samarth Life Sciences Pvt. Ltd
Pace Biotech Limited
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
바소프레서 시장 2029 : 새로운 기회를 제공하는 국가
바소프레서 시장 2029 : 새로운 기회를 제공하는 부문
바소프레서 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
A vasopressor is a drug that constricts blood vessels, raising blood pressure by enhancing vascular tone. It is primarily used in critical care to manage severe hypotension and ensure adequate blood flow to vital organs. By stabilizing circulation, vasopressors help prevent life-threatening complications in critically ill patients.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main types of vasopressors include catecholamines, non-catecholamines, and vasopressin. Catecholamines are hormones such as dopamine, norepinephrine, and epinephrine, produced by the adrenal glands and involved in the body's stress response. These drugs can be administered through various routes, such as intravenous (IV), intraosseous, and inhalational methods, for applications such as managing hypotension, treating septic shock, supporting cardiogenic shock, post-surgical management, and others. They are used in various settings, including hospitals, ambulatory surgical centers, emergency medical services, and home care.
The vasopressor market research report is one of a series of new reports from The Business Research Company that provides vasopressor market statistics, including vasopressor industry global market size, regional shares, competitors with a vasopressor market share, detailed vasopressor market segments, market trends and opportunities, and any further data you may need to thrive in the vasopressor industry. This vasopressor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The vasopressor market size has grown strongly in recent years. It will grow from$3.51 billion in 2024 to $3.76 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to several factors, including the increasing geriatric population, rising healthcare expenditure, expanding government initiatives, a growing number of hospitals, and the increasing prevalence of cardiovascular diseases.
The vasopressor market size is expected to see strong growth in the next few years. It will grow to$4.92 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth during the forecast period can be attributed to several factors, including the rising incidence of hypertension, greater adoption of advanced sepsis management guidelines, increasing investments in critical care technologies, the growing prevalence of septic shock, and a rising demand for personalized critical care. Key trends during this period include advancements in drug formulations, the development of tailored therapies, technological innovations in smart infusion pumps, the integration of telemedicine with vasopressor therapy, and innovations in biodegradable vasopressor implants.
The growing prevalence of heart diseases is anticipated to fuel the expansion of the vasopressor market in the coming years. Heart diseases encompass a range of conditions that affect the heart's structure and functionality, including coronary artery disease, arrhythmias, heart failure, and congenital heart defects. With the rise in sedentary lifestyles, obesity and poor cardiovascular health are becoming more common, substantially elevating the risk of heart-related conditions. Vasopressors aid in the treatment of heart disease by constricting blood vessels, which helps raise blood pressure and enhance blood flow to vital organs, thus supporting cardiovascular function during critical states. For example, in December 2023, the Australian Institute of Health and Welfare, a government agency in Australia, reported that doctor-certified deaths due to coronary heart disease (CHD) rose from 14,100 in 2021 to 14,900 in 2022. Consequently, the increasing rate of heart disease is contributing to the growth of the vasopressor market.
Leading players in the vasopressor market are concentrating on the development of advanced solutions such as intravenous (IV) vasopressors to better regulate blood pressure and improve patient outcomes. IV vasopressors are employed to constrict blood vessels and raise blood pressure in patients suffering from severe hypotension or shock, thereby ensuring sufficient blood flow to essential organs. For instance, in June 2023, Fresenius Kabi AG, a pharmaceutical company based in Germany, introduced Vasopressin Injection, USP, a generic version of Vasostrict, in the U.S. market, broadening its critical care product lineup. This drug is specifically indicated for adults experiencing vasodilatory shock who remain hypotensive after receiving fluids and catecholamines. It comes in a single-dose vial containing 20 units per 1 mL.
In April 2024, Endo Inc., a pharmaceutical company based in the United States, acquired assets from Endo International plc (EIP) for an undisclosed amount. Through this acquisition, Endo Inc. aims to enhance its financial stability, expand its product range, foster innovation, gain operational efficiencies, and strategically position itself for future growth in the pharmaceutical sector. Endo International plc, headquartered in Ireland, is a pharmaceutical firm known for manufacturing and distributing vasopressin.
Major players in the vasopressor market are Pfizer Inc., Merck And Co Inc., Novartis AG, Baxter International Inc., Fresenius Kabi AG, Bauch & Lomb Incorporated, Dr. Reddy's Laboratories Limited, Hikma Pharmaceuticals PLC, Endo Inc., Amphastar Pharmaceuticals Inc., American Regent Incorporated, Celon Laboratories Ltd., Athenex Inc., Sagent Pharmaceuticals Inc., Civica Rx, Eton Pharmaceuticals Inc., Amomed Pharma GmbH, Health Biotech Limited, Samarth Life Sciences Pvt. Ltd, and Pace Biotech Limited.
North America was the largest region in the vasopressor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in vasopressor report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the vasopressor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The vasopressor market consists of sales of norepinephrine, epinephrine, dopamine, and phenylephrine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Vasopressor Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on vasopressor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for vasopressor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vasopressor market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Catecholamines; Non-Catecholamines; Vasopressin
2) By Route Of Administration: Intravenous (IV); Intraosseous; Inhalational
3) By Applications: Hypotension Management; Septic Shock Treatment; Cardiogenic Shock Support; Post-Surgical Management; Other Critical Care Applications
4) By End Users: Hospitals; Ambulatory Surgical Centers; Emergency Medical Services; Home Care Settings
Subsegments:-
1) By Catecholamines: Norepinephrine; Epinephrine; Dopamine; Isoproterenol
2) By Non-Catecholamines: Phenylephrine; Angiotensin II
3) By Vasopressin: Vasopressin
Companies Mentioned: Pfizer Inc.; Merck And Co Inc.; Novartis AG; Baxter International Inc.; Fresenius Kabi AG
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Vasopressor Market Characteristics
3. Vasopressor Market Trends And Strategies
4. Vasopressor Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Vasopressor Growth Analysis And Strategic Analysis Framework
5.1. Global Vasopressor PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Vasopressor Market Growth Rate Analysis
5.4. Global Vasopressor Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Vasopressor Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Vasopressor Total Addressable Market (TAM)
6. Vasopressor Market Segmentation
6.1. Global Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Catecholamines
Non-Catecholamines
Vasopressin
6.2. Global Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous (IV)
Intraosseous
Inhalational
6.3. Global Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypotension Management
Septic Shock Treatment
Cardiogenic Shock Support
Post-Surgical Management
Other Critical Care Applications
6.4. Global Vasopressor Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centers
Emergency Medical Services
Home Care Settings
6.5. Global Vasopressor Market, Sub-Segmentation Of Catecholamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Norepinephrine
Epinephrine
Dopamine
Isoproterenol
6.6. Global Vasopressor Market, Sub-Segmentation Of Non-Catecholamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Phenylephrine
Angiotensin II
6.7. Global Vasopressor Market, Sub-Segmentation Of Vasopressin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vasopressin (Desmopressin)
7. Vasopressor Market Regional And Country Analysis
7.1. Global Vasopressor Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Vasopressor Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Vasopressor Market
8.1. Asia-Pacific Vasopressor Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Vasopressor Market
9.1. China Vasopressor Market Overview
9.2. China Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Vasopressor Market
10.1. India Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Vasopressor Market
11.1. Japan Vasopressor Market Overview
11.2. Japan Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Vasopressor Market
12.1. Australia Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Vasopressor Market
13.1. Indonesia Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Vasopressor Market
14.1. South Korea Vasopressor Market Overview
14.2. South Korea Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Vasopressor Market
15.1. Western Europe Vasopressor Market Overview
15.2. Western Europe Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Vasopressor Market
16.1. UK Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Vasopressor Market
17.1. Germany Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Vasopressor Market
18.1. France Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Vasopressor Market
19.1. Italy Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Vasopressor Market
20.1. Spain Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Vasopressor Market
21.1. Eastern Europe Vasopressor Market Overview
21.2. Eastern Europe Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Vasopressor Market
22.1. Russia Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Vasopressor Market
23.1. North America Vasopressor Market Overview
23.2. North America Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Vasopressor Market
24.1. USA Vasopressor Market Overview
24.2. USA Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Vasopressor Market
25.1. Canada Vasopressor Market Overview
25.2. Canada Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Vasopressor Market
26.1. South America Vasopressor Market Overview
26.2. South America Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Vasopressor Market
27.1. Brazil Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Vasopressor Market
28.1. Middle East Vasopressor Market Overview
28.2. Middle East Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Vasopressor Market
29.1. Africa Vasopressor Market Overview
29.2. Africa Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Vasopressor Market Competitive Landscape And Company Profiles
30.1. Vasopressor Market Competitive Landscape
30.2. Vasopressor Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck And Co Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
31. Vasopressor Market Other Major And Innovative Companies
31.1. Bauch & Lomb Incorporated
31.2. Dr. Reddy's Laboratories Limited
31.3. Hikma Pharmaceuticals PLC
31.4. Endo Inc.
31.5. Amphastar Pharmaceuticals Inc.
31.6. American Regent Incorporated
31.7. Celon Laboratories Ltd.
31.8. Athenex Inc.
31.9. Sagent Pharmaceuticals Inc.
31.10. Civica Rx
31.11. Eton Pharmaceuticals Inc.
31.12. Amomed Pharma GmbH
31.13. Health Biotech Limited
31.14. Samarth Life Sciences Pvt. Ltd
31.15. Pace Biotech Limited
32. Global Vasopressor Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Vasopressor Market
34. Recent Developments In The Vasopressor Market
35. Vasopressor Market High Potential Countries, Segments and Strategies
35.1 Vasopressor Market In 2029 - Countries Offering Most New Opportunities
35.2 Vasopressor Market In 2029 - Segments Offering Most New Opportunities
35.3 Vasopressor Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250617_r35014_Vasopressor_GMR_2025
(주)글로벌인포메이션02-2025-2992kr-info@giikorea.co.kr ⓒ Copyright Global Information, Inc. All rights reserved.
